Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is not a good sign this fall in volumes.
Mistake?
Dilution over?
Are pessimists do not believe that it can
Off the title?
I regret that I see dead volume.
Bag,
I am not capable is the first thread
I open forum, I would be happy to have you at my side
You alone you can add?
With pleasure,
You can add alone or should I do it?
I do not see auto MM (diluter)
Excellent signal ..
Corgenix Reports Second Quarter Fiscal 2008 Financial Results
Tuesday February 12, 9:15 am ET
Revenues for the Quarter Increase More Than 42% over Prior Year
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX - News), a worldwide developer and marketer of diagnostic test kits, today filed its 2nd quarter Form 10-QSB and reported financial results. The report disclosed that the company’s sales and operating results have advanced during the quarter and six months ended December 31, 2007, and further confirmed that the initiatives the company put in place several months earlier are proving very effective. Some of the results highlighted by the report are as follows:
Revenues for the quarter increased $714,227 or 42.4% over the prior year’s comparable quarter.
Total operating expenses decreased $326,074 or 22.5% vs. the prior year’s comparable quarter.
Operating income for the quarter was $224,224 vs. an operating loss of $435,039 in the prior year’s comparable quarter.
Net loss was dramatically reduced from $908,121 in the prior year’s comparable quarter to $60,310 in the current quarter.
“The initiatives which we implemented beginning in the final quarter of fiscal 2007 to increase sales and decrease operating expenses are definitely showing positive results,” said Douglass Simpson, President and CEO of Corgenix. “While we still have more work to do, these initiatives have materially reduced our operating expenses, improved our customer and sales experience and laid the groundwork to accelerate future revenue growth. Our Company is growing nicely and is very vibrant.”
The Company noted that the financial performance for the quarter was strong, with notable growth in core product revenue and substantially reduced net negative cash flow. The Company expects that Fiscal Year 2008 will be another record year for revenues.
“We are continuing to build a solid foundation for AspirinWorks®. Even though sales are not yet material, they are right on budget and should begin to pay off later in the current fiscal year, and especially in the years to come,” noted Luis Lopez, M.D., Corgenix Chairman and Chief Medical Officer. “Our AspirinWorks® and AtherOx® products are currently in over 34 clinical studies worldwide and we expect to see exciting news as these studies are completed and move to publication.”
Second Quarter 2008 Conference Call Details
Corgenix invites all those interested in hearing management's discussion of second quarter results to join a shareholders conference call on Tuesday, February 12, 2008, at 4:00 PM EST (2:00 PM MST). Interested parties can join the call by dialing 800-895-0198. International participants may access the call by dialing 785-424-1053. The conference code is “CORGENIX.” A replay will be available for 30 days following the call by dialing 800-727-6189 for domestic participants and 402-220-2671 for international participants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com.
Statements in this press release that are not strictly historical facts are “forward-looking” statements (identified by the words “believe,” “estimate,” “project,” “expect” or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the company does not undertake any obligation to publicly update or revise any forward-looking statements.
SUMMARY OF FINANCIAL HIGHLIGHTS
($000 of U.S. dollars except shares outstanding and per share amounts)
CORGENIX MEDICAL CORPORATION AND SUBSIDIARIES
OPERATIONAL DATA
Three Months Ended
Six Months Ended
December
a/s o/s ?
thanks
Yet few days dilution,
And then we will be repaid.
Long
All standing still.
Yet dilution
Lee woken you are sleeping ..
Without this title story is dead.
gooo,,,,,
0,0015 today
If I am not mistaken dilution came ..
Has 486M shares
Am new here.
Would need compelling reasons to become
Shareholder of the company '...
Thanks to all of you
Immediately clarify my position ...
For what I see in these last days
After news have greatly diluted
Putting the brake on 0,0005-6 printing quote ...
The company has received several money now arrived
The time to do the shareholders gain ....
In this world does so first earns the company then
Shareholders ...
Is the law of the case ...
Now molleranno brakes until 0001-20 then print actions
Get off without quotes diaaf.
Diaaf is distributed at a company well known in the world.
Google has put his enormous hands on diaaf.
Things can change in a nanosecond ..
I would be happy to read that google buy the subsidiary of diaaf.
And only my opinion
As missing to end the dilution?
yes,,,0,003
You say ...
Now we have to establish safety belts
We are launching pad ...
Are here again '
Kindly something I can say
o/s a/s updated ...
Thanks
By the seventh next to the family
Rcch ...
Tomorrow we enter the radar ....
Dilution volume boom ended after
The news now it is high time
To become a serious company ... have printed everything possible
Monday will scale the mountain ....
Diaaf go.
trust your words ..!
Know, I am Italian, I have to wake up very soon
To make contact with ceo ....
Seems a good company zero debt is a good thing!
Thanks for the information ..
I will be your seventh next ...
I hope to enter the lowest present value
I read that did not confirm debt?
I hope that the ceo is an honest person ...
Share Structure:OS 91,700,000 shares;float 10,000,000 appr.
ok???
Roo hello ..
If you have time call ceo
I can not ...
Are here again '
Please tell me a / s? O / s? Current ..
Thanks
Why these upside?
A/s o/S current .. thanks
Have finished printing?
You can start ....
ALSO A child sees that the title is driven
By diluter unworthy
Avranni when finished print then 0.0006
Can take share.
Bad sign MM ask AUTO
Diluter murderess ...
As you can see the bag is strange
Yesterday a com boom of us volumes rose by 66%
Today with a paltry volume us 40%
We are going with the brake pulled ...
Fault of MM ... must sell more 'actions
Possible 0.0006
Just my thoughts.
diaaf,,,go go go
yes,,,go go go
When you sell 5000K aks good sign
Strong hands to buy bid